This article is more than 5 years old. Information may no longer be current.

CIBA Vision files patent infringement lawsuit against Bausch & Lomb in Ireland

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA — CIBA Vision announced that Novartis AG has filed a patent infringement lawsuit on its behalf against Bausch & Lomb in Ireland. The suit claims that Bausch & Lomb’s PureVision contact lenses infringe an Irish patent that protects the unique technology used to develop CIBA Vision’s Focus Night & Day contact lenses, which allow 30 nights of continuous wear. Novartis is seeking to have the court prohibit Bausch & Lomb from manufacturing and selling its infringing product in Ireland.

Bausch & Lomb has released the following statement in response: “This is just another part of the long worldwide battle between Bausch & Lomb and CIBA Vision over patent rights covering silicone hydrogel extended-wear contact lens technology. In the Ireland litigation — as in other cases — Bausch & Lomb will vigorously defend its belief that the company’s PureVision lens technology is unique and does not infringe the patent in question.”